Verisk's ISO ClaimSearch Accelerator Receives Ready for Guidewire Designation
Customers can quickly access loss history reports in new, visualized platform
After Yesterday's Rally of 1.09% Shares Could Potentially Pullback
Verisk Analyti (NASDAQ:VRSK) traded in a range yesterday that spanned from a low of $140.84 to a high of $141.13. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $140.96 on volume of 361,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Verisk Analyti Has Returned 26.0% Since SmarTrend Recommendation (VRSK)
SmarTrend identified an Uptrend for Verisk Analyti (NASDAQ:VRSK) on January 10th, 2019 at $111.84. In approximately 4 months, Verisk Analyti has returned 25.98% as of today's recent price of $140.90.
IntelliCorp Announces Advanced Drug Screening Solution for Background Screening
Intellicorp Records, Inc., a Verisk (Nasdaq:VRSK) business, announced today an advanced drug screening solution integrated into the company's background check ordering process. IntelliCorp is an award-winning provider of employment and volunteer screening services for businesses and nonprofit organizations.
P/C Insurers Report 66 Percent Increase in Net Income in 2018
Increase driven by growth in premiums and decline in catastrophe losses
Verisk Announces Plans to Leverage Electronic Health Record Data from Human API for New Life Insurance Underwriting and Portfolio Tools
JERSEY CITY, N.J., and SAN MATEO, Calif., April 25, 2019 - Verisk (Nasdaq:VRSK), a leading data analytics provider, and Human API, the nation's largest health data network, announced today plans to work together on Verisk's new InsurTech tools. Leveraging electronic health record (EHR) data collected by Human API, Verisk's solutions will help revolutionize how life insurers underwrite coverage and manage in-force portfolios.
Verisk Financial | G2 Launches New Global Solution to Help Identify Risk Associated with Illegal Pharmaceutical Sales
BELLEVUE, Wash., April 24, 2019 - G2 has launched a new service, G2 Pharma360TM, to better protect merchant acquirers, payment processors, and pharmaceutical merchants from card-brand assessments and the legal risk that comes with onboarding pharmaceutical merchants. G2, a Verisk (Nasdaq:VRSK) business and division of Verisk Financial, is a leading global provider of merchant risk management solutions.
IntelliCorp Announces Enhanced Pre-Adverse and Adverse Action Solution for Background Screening
Intellicorp Records, Inc., a Verisk (Nasdaq:VRSK) business, announced today an enhanced solution for Pre-Adverse and Adverse Action notices, a required component of the background screening process under the Fair Credit Reporting Act (FCRA) and state and local legislation. IntelliCorp is an award-winning provider of background checks and employment screening services for businesses and nonprofit organizations.
SERVPRO(R) Adopts Xactware Job Management Tools
Xactware's Restoration Manager aligns with SERVPRO's WorkCenter tools to deliver best-in-class job management solution